DASA announces extraordinary shareholder meeting
Reuters2026/08/03 21:32- Dasa will hold an extraordinary shareholders’ meeting in Barueri, São Paulo state on Aug. 3, 2026.
- Shareholders will vote on the proposed merger of Patologia Clínica Dr. Geraldo Lustosa Cabral into Dasa.
- The meeting will also consider appointing Apsis Consultoria e Avaliações as independent appraiser and approving its valuation report.
- The valuation sets the target’s net assets at BRL 16.22 million as of March 31, 2026, adjusted for lease-accounting items.
- Management will also seek authorization to complete steps required to implement the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Liquidity Unconcerned? The Federal Reserve Hits 'Pause' Again, Ceasing Reserve Management Bond Purchases Until Mid-October
The Federal Reserve announced on Monday that it will not conduct short-term Treasury bond purchases for reserve management purposes in the next phase for the second consecutive month, indicating that policymakers are satisfied with the level of bank reserves in the financial system.
Trump connects with Jensen Huang: Slams AI threat as a "scam" and strongly supports data centers, calling them the "oil of the future"
Trump participated in a live call with Jensen Huang, denouncing the AI threat narrative as a scam and stating that data centers are the oil of the future. Despite Nvidia's stock price dropping due to slowdown concerns, Jensen Huang still responded to security warnings.
AI Risks and Calls for "Slowdown" Intensify; U.S. Cybersecurity Stocks Surge Collectively
On Monday, cybersecurity stocks generally rose. As concerns grow among investors about the potential harm artificial intelligence could cause to humanity, and some industry leaders call for slowing down AI development, capital is shifting toward the cybersecurity and related enterprise software sectors.
Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58
Crypto prices
More
